36 related articles for article (PubMed ID: 10464021)
1. F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profile.
Newman-Tancredi A; Assié MB; Martel JC; Cosi C; Slot LB; Palmier C; Rauly-Lestienne I; Colpaert F; Vacher B; Cussac D
Br J Pharmacol; 2007 May; 151(2):237-52. PubMed ID: 17375087
[TBL] [Abstract][Full Text] [Related]
2. Ensaculin (KA-672 HCl): a multitransmitter approach to dementia treatment.
Hoerr R; Noeldner M
CNS Drug Rev; 2002; 8(2):143-58. PubMed ID: 12177685
[TBL] [Abstract][Full Text] [Related]
3.
Kaczor AA; Targowska-Duda KM; Silva AG; Kondej M; Biała G; Castro M
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32102432
[No Abstract] [Full Text] [Related]
4. Efficient enzymatic synthesis of chiral 2,3-dihydro-1,4-benzodioxane motif using engineered
Wu Z; Shi W; Jin M; Zhou W
RSC Adv; 2023 Jun; 13(27):18953-18959. PubMed ID: 37350861
[TBL] [Abstract][Full Text] [Related]
5. Dopamine Receptor Ligand Selectivity-An In Silico/In Vitro Insight.
Zell L; Bretl A; Temml V; Schuster D
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239139
[TBL] [Abstract][Full Text] [Related]
6. Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112).
McComsey DF; Smith-Swintosky VL; Parker MH; Brenneman DE; Malatynska E; White HS; Klein BD; Wilcox KS; Milewski ME; Herb M; Finley MF; Liu Y; Lubin ML; Qin N; Reitz AB; Maryanoff BE
J Med Chem; 2013 Nov; 56(22):9019-30. PubMed ID: 24205976
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the behavioral and pharmacokinetic profile of SYA013, a homopiperazine analog of haloperidol in rats.
Bricker B; Jackson T; Boateng B; Zhu XY; Ablordeppey SY
Pharmacol Biochem Behav; 2012 Aug; 102(2):294-301. PubMed ID: 22588199
[TBL] [Abstract][Full Text] [Related]
8. Benzothiazoles as probes for the 5HT1A receptor and the serotonin transporter (SERT): a search for new dual-acting agents as potential antidepressants.
Zhu XY; Etukala JR; Eyunni SV; Setola V; Roth BL; Ablordeppey SY
Eur J Med Chem; 2012 Jul; 53():124-32. PubMed ID: 22520153
[TBL] [Abstract][Full Text] [Related]
9. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
Kuroki T; Nagao N; Nakahara T
Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
[TBL] [Abstract][Full Text] [Related]
10. The role of serotonin receptors in the action of atypical antipsychotic drugs.
Meltzer HY; Massey BW
Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906
[TBL] [Abstract][Full Text] [Related]
11. N-Substituted (2,3-dihydro-1,4-benzodioxin-2-yl)methylamine derivatives as D(2) antagonists/5-HT(1A) partial agonists with potential as atypical antipsychotic agents.
Birch AM; Bradley PA; Gill JC; Kerrigan F; Needham PL
J Med Chem; 1999 Aug; 42(17):3342-55. PubMed ID: 10464021
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
Homan EJ; Copinga S; Unelius L; Jackson DM; Wikström HV; Grol CJ
Bioorg Med Chem; 1999 Jul; 7(7):1263-71. PubMed ID: 10465402
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
14. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291
[TBL] [Abstract][Full Text] [Related]
15. Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics.
Raviña E; Negreira J; Cid J; Masaguer CF; Rosa E; Rivas ME; Fontenla JA; Loza MI; Tristán H; Cadavid MI; Sanz F; Lozoya E; Carotti A; Carrieri A
J Med Chem; 1999 Jul; 42(15):2774-97. PubMed ID: 10425088
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
